To the Editor In the last 3 decades, several randomized clinical trials (RCTs) have compared percutaneous coronary interventions (PCIs) with coronary artery bypass grafting (CABG) for the revascularization of patients with coronary artery disease (CAD). In the meta-analysis by Gaudino and colleagues,1 the authors pooled 23 RCTs and concluded that PCI was associated with higher 5-year cardiac as well as noncardiac mortality.
Rodríguez-Granillo AM, Fernández-Pereira C, Rodríguez AE. Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention. JAMA Intern Med. 2021;181(7):1012–1013. doi:10.1001/jamainternmed.2021.0030
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.